Affiliation:
1. Vanke School of Public Health Tsinghua University Beijing China
Abstract
AbstractFrom an economic perspective, large investments in medical equipment are justifiable only when many patients benefit. Although rural hospitals play a crucial role locally, the treatments they can offer are limited. In this study, I characterize investment level that maximizes the total surplus, encompassing patients' welfare and producer surplus, and subtracting treatment costs. Specifically, I account for economic externalities generated by the investment in the rural hospital and for different utility losses that patients suffer when they cannot be treated locally. I demonstrate that the optimal investment level can be implemented if the Health Authority has the power to set specific prices for each disease. Additionally, I explore a decentralized situation wherein the investment decision lies with the rural hospital manager, and the Health Authority can only make a discrete decision between two payment systems: Fee‐for‐service, which covers all treatment costs, or Diagnosis‐Related‐Groups, which reimburses a price per patient based on the overall average cost. I find that the Diagnosis‐Related‐Groups system outperforms the Fee‐for‐service in terms of total surplus when the treatment cost at the rural hospital is lower. However, when the rural hospital has higher costs and the Health Authority seeks to incentivize investment, the Fee‐for‐service system is superior.
Funder
Southeast University
University College Dublin
Reference74 articles.
1. Advisory Council on Health Care. (2018).Advisory council on the assessment of developments in the health care system. Short summary of the report 2018: Needs‐based regulation of the health care provision.
2. A high‐tech advantage. Rural hospitals hope offering latest technology keeps patients close to home;Barr P.;Modern Healthcare,2012
3. The Interaction between Forms of Insurance Contract and Types of Technical Change in Medical Care
4. The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks